BioHarvest's olive cell compound reduced fat accumulation in liver cells in preclinical models, showing potential liver health benefits. The company plans to launch the Olive Cell product as a ...
BioHarvest demonstrated that in human hepatic (liver) cells, the Olive Cell compound mitigated fat accumulation in a liver steatosis model as well as in experimental models of liver fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback